先进的原发性高氧化类型的自然史1:一个回顾性研究
John C Lieske1, Jaap W Groothoff2, Yaacov Frishberg3
1Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
Kidney medicine
|November 10, 2025
概括
先进的1型原发性高氧化尿症 (PH1) 对患者产生重大影响,导致高发病率和死亡率. 这项研究突出了PH1的严重自然历史,强调需要更好的管理策略.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 遗传学 是一个遗传学.
- 罕见疾病 罕见疾病
背景情况:
- 初级高氧化尿1型 (PH1) 是一种罕见的遗传性疾病.
- PH1导致过度的氧化酸盐生产和沉积在脏和其他器官中.
- 先进的PH1与严重的损伤和全身并发症有关.
研究的目的:
- 描述先进的1型原发性高氧化尿症 (PH1) 的自然史.
- 分析PH1患者的跨国队列中的结果.
- 确定影响PH1发病率和死亡率的关键临床事件和因素.
主要方法:
- 复杂PH1.1患者的回顾性图表审查.
- 纳入标准: ≥4次PH1相关访问,≥6个月的随访 (或已故),以及功能受损 (eGFR ≤45mL/min/1.73m2或肌素升高).
- 患者分为非透析 (A组) 和血液透析 (B组) 组.
主要成果:
- 分析了70名患者,使用了长达21年的数据.
- 在非透析患者中,估计的淋巴膜过率 (eGFR) 斜率为-2.8mL/min/1.73m2/年.
- 42名患者接受了移植,19名患者死亡,非移植患者的死亡率更高 (39.3%对19.0%).
结论:
- 高级PH1的特点是患病率和死亡率高.
- 移植提供了生存益处,但系统性氧化的恢复可能会延长.
- 新出现的临床事件,如结石和骨折是常见的,强调PH1.1的系统性影响.
更多相关视频
09:40Isolation, Characterization, And High Throughput Extracellular Flux Analysis of Mouse Primary Renal Tubular Epithelial Cells
Published on: June 20, 2018
18.4K
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
24.3K
相关概念视频
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:25Chronic Kidney Disease I: Introduction
552
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
552
01:24Chronic Kidney Disease II: Clinical Manifestations
537
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
537
01:26Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
358
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
358